Sign up to save your podcasts
Or
Share New Therapies for Neovascular AMD and DME: What Have We Learned?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
New Therapies for Neovascular AMD and DME: What Have We Learned?
Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).
Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu
View all episodes
By Medscape Podcasts
4
77 ratings
Latest real-world evidence with long-durability therapies for neovascular age-related macular degeneration (AMD) and diabetic macular edema (DME).
Credit available for this activity expires: 10/23/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/997563?ecd=bdc_podcast_libsyn_mscpedu
More shows like Keeping Current
View all
JAMA Editors' Summary
138 Listeners
The Bob Harrington Show
13 Listeners
NEJM This Week
320 Listeners
Diabetes Core Update
101 Listeners
This Week in Cardiology
883 Listeners
JAMA Clinical Reviews
501 Listeners
One-on-One with Eric Topol
17 Listeners
Mayo Clinic Talks
289 Listeners
The Curbsiders Internal Medicine Podcast
3,340 Listeners
JAMA Medical News
88 Listeners
Core IM | Internal Medicine Podcast
1,150 Listeners
Annals On Call Podcast
188 Listeners
The Clinical Problem Solvers
514 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
367 Listeners
Medicine and the Machine
61 Listeners
Keeping Current CME
26 Listeners
Cardionerds: A Cardiology Podcast
432 Listeners
The Curious Clinicians
372 Listeners